CRDF
Cardiff Oncology, Inc.
Cardiff Oncology, Inc. (CRDF) has 4 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 16, 2026.
Insiders have net bought $1.1M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Mani Mohindru
- Employees:31
- HQ:San Diego, CA, US
- IPO:2004-07-27
Insider Buying
$1.1M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$55.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 687,285 | $1000K | Jul 16 | SEC ↗ | |
| Chief Executive Officer | Purchase | 34,364 | $50K | Jul 16 | SEC ↗ | |
PACE GARY WFirst filing | Director | Purchase | 30,000 | $37K | Jun 22 | SEC ↗ |
Mohindru ManiFirst filing | Chief Executive Officer | Purchase | 24,703 | $30K | Jun 22 | SEC ↗ |
Related companies
Cardiff Oncology, Inc. is in the Healthcare sector.